Bhatia, N. , Kantor, J. , Green, L. , Weiss, J. , Willson, C., Cutler, S., Rieger, J., Glover, D.K., Rumney, P. and Goldenberg, G. 2023. Results from Part 1 Safety Run-in Period of a 2-part, Phase 2, Multicenter, Open-label, Proof-of-Concept Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of VP-315 in Subjects with Basal Cell Carcinoma. SKIN The Journal of Cutaneous Medicine. 7, 6 (Nov. 2023), s260. DOI:https://doi.org/10.25251/skin.7.supp.260.